Comments
Dr Reddy’s Laboratories Ltd has launched naloxone hydrochloride injection pre-filled syringes in the US market.
The launched product is a therapeutic equivalent generic version of Narcan injection approved by the USFDA.
“We are pleased to bring our second product to market that has been designated as a competitive generic therapy (CGT) by the USFDA,” Marc Kikuchi, Chief Executive Officer, North America Generics, Dr Reddy’s Laboratories, said in a release. “With a CGT designation, we have 180-day CGT exclusivity to market this product.”
Naloxone hydrochloride injections had US sales of approximately $31 million for the 12 months ended January 2020, according to IQVIA Health data.
Dr Reddy’s naloxone hydrochloride injection is available in 2 mL single-dose prefilled syringes.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.